Lexaria Bioscience Corp

For the period ended Aug 31, 2024. Filed Nov 26, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Nov 26, 2024

LEXX$4.50+7.9%Stored close · as of Nov 6, 2026

Opening this filing…